.png)
Synthetic Cannabinoids Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 158 Category: Pharma & Healthcare Report Code : HC0115207
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Synthetic Cannabinoids Market By Type (High-Pure Synthetic Cannabinoid, Ultra-Pure Synthetic Cannabinoid, Others) and Application (Pharmaceutical, Consumer Good, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Synthetic Cannabinoids Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Synthetic Cannabinoidsare agonists of the cannabinoid receptors. They have been designed to be similar to the natural cannabinoid with the strongest binding affinity to the CB1 receptor, which is linked to the psychoactive effects of marijuana.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Synthetic Cannabinoids Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Noramco
- Lygos (Librede)
- CV Sciences
- Hyasynth Biologicals
- Renew Biopharma
- Insys Therapeutics
- CannBioRx Life Sciences
- Ginkgo Bioworks
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Synthetic Cannabinoids Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o High-Pure Synthetic Cannabinoid
o Ultra-Pure Synthetic Cannabinoid
o Others
· Synthetic Cannabinoids Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Pharmaceutical
o Consumer Good
o Others
· Synthetic Cannabinoids Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Noramco
o Lygos (Librede)
o CV Sciences
o Hyasynth Biologicals
o Renew Biopharma
o Insys Therapeutics
o CannBioRx Life Sciences
o Ginkgo Bioworks
· Synthetic Cannabinoids Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Synthetic Cannabinoids Market, By Country
o U.S. Synthetic Cannabinoids Market
o Canada Synthetic Cannabinoids Market
o Mexico Synthetic Cannabinoids Market
o Europe
§ Europe Synthetic Cannabinoids Market, By Country
o UK Synthetic Cannabinoids Market
o Germany Synthetic Cannabinoids Market
o France Synthetic Cannabinoids Market
o Russia Synthetic Cannabinoids Market
o Italy Synthetic Cannabinoids Market
o Rest of Europe Synthetic Cannabinoids Market
o Asia-Pacific
§ Asia-Pacific Synthetic Cannabinoids Market, By Country
o China Synthetic Cannabinoids Market
o Japan Synthetic Cannabinoids Market
o South Korea Synthetic Cannabinoids Market
o India Synthetic Cannabinoids Market
o Southeast Asia Synthetic Cannabinoids Market
o Rest of Asia-Pacific Synthetic Cannabinoids Market
o South America
§ South America Synthetic Cannabinoids Market
o Brazil Synthetic Cannabinoids Market
o Argentina Synthetic Cannabinoids Market
o Columbia Synthetic Cannabinoids Market
o Rest of South America Synthetic Cannabinoids Market
o Middle East and Africa
§ Middle East and Africa Synthetic Cannabinoids Market
o Saudi Arabia Synthetic Cannabinoids Market
o UAE Synthetic Cannabinoids Market
o Egypt Synthetic Cannabinoids Market
o Nigeria Synthetic Cannabinoids Market
o South Africa Synthetic Cannabinoids Market
o TurkeySynthetic Cannabinoids Market
o Rest of MEA Synthetic Cannabinoids Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Synthetic Cannabinoids Market, By Type
5.1. Introduction
5.2. Global Synthetic Cannabinoids Revenue and Market Share by Type (2017-2021)
5.2.1. Global Synthetic Cannabinoids Revenue and Revenue Share by Type (2017-2021)
5.3. High-Pure Synthetic Cannabinoid
5.3.1. Global High-Pure Synthetic Cannabinoid Revenue and Growth Rate (2017-2021)
5.4. Ultra-Pure Synthetic Cannabinoid
5.4.1. Global Ultra-Pure Synthetic Cannabinoid Revenue and Growth Rate (2017-2021)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2021)
6. Synthetic Cannabinoids Market, By Applications
6.1. Introduction
6.2. Global Synthetic Cannabinoids Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Synthetic Cannabinoids Revenue and Revenue Share by Applications (2017-2021)
6.3. Pharmaceutical
6.3.1. Global Pharmaceutical Revenue and Growth Rate (2017-2021)
6.4. Consumer Good
6.4.1. Global Consumer Good Revenue and Growth Rate (2017-2021)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2021)
7. Synthetic Cannabinoids Market, By Region
7.1. Introduction
7.2. Global Synthetic Cannabinoids Revenue and Market Share by Regions
7.2.1. Global Synthetic Cannabinoids Revenue by Regions (2017-2021)
7.3. North America Synthetic Cannabinoids by Countries
7.3.1. North America Synthetic Cannabinoids Revenue and Growth Rate (2017-2021)
7.3.2. North America Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Synthetic Cannabinoids by Countries
7.4.1. Europe Synthetic Cannabinoids Revenue and Growth Rate (2017-2021)
7.4.2. Europe Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Synthetic Cannabinoids by Countries
7.5.1. Asia-Pacific Synthetic Cannabinoids Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Synthetic Cannabinoids by Countries
7.6.1. South America Synthetic Cannabinoids Revenue and Growth Rate (2017-2021)
7.6.2. South America Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Synthetic Cannabinoids by Countries
7.7.1. Middle East and Africa Synthetic Cannabinoids Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Noramco
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Lygos (Librede)
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. CV Sciences
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Hyasynth Biologicals
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Renew Biopharma
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Insys Therapeutics
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. CannBioRx Life Sciences
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Ginkgo Bioworks
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Synthetic Cannabinoids Market Forecast (2022-2027)
9.1. Global Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Synthetic Cannabinoids Market Forecast by Regions (2022-2027)
9.2.1. North America Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.1.1. United States Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.1.2. Canada Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.1.3. Mexico Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2. Europe Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.1. Germany Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.2. France Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.3. UK Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.4. Russia Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.5. Italy Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3. Asia-Pacific Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.1. China Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.2. Japan Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.3. Korea Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.4. India Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.4. South America Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.4.1. Brazil Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.4.2. Argentina Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.4.3. Columbia Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.4.4. Rest of South America Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5. Middle East and Africa Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.3. Egypt Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.4. Nigeria Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.5. South Africa Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.6. Turkey Synthetic Cannabinoids Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Synthetic Cannabinoids Market Forecast (2022-2027)
9.3. Synthetic Cannabinoids Market Forecast by Type (2022-2027)
9.3.1. Synthetic Cannabinoids Forecast by Type (2022-2027)
9.3.2. Synthetic Cannabinoids Market Share Forecast by Type (2022-2027)
9.4. Synthetic Cannabinoids Market Forecast by Applications (2022-2027)
9.4.1. Synthetic Cannabinoids Forecast by Applications (2022-2027)
9.4.2. Synthetic Cannabinoids Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Synthetic Cannabinoids Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Synthetic Cannabinoids Revenue and Revenue Share by Type (2017-2019)
Figure Global High-Pure Synthetic Cannabinoid Revenue and Growth Rate (2017-2019)
Figure Global Ultra-Pure Synthetic Cannabinoid Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Synthetic Cannabinoids Revenue and Revenue Share by Applications (2017-2019)
Figure Global Pharmaceutical Revenue and Growth Rate (2017-2019)
Figure Global Consumer Good Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Synthetic Cannabinoids Revenue by Regions (2017-2019)
Figure North America Synthetic Cannabinoids Growth Rate (2017-2019)
Figure North America Synthetic Cannabinoids Revenue and Growth Rate (2017-2019)
Figure North America Synthetic Cannabinoids by Countries (2017-2019)
Figure North America Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2019)
Figure United States Synthetic Cannabinoids Growth Rate (2017-2019)
Figure United States Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Canada Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Mexico Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Europe Synthetic Cannabinoids Revenue and Growth Rate (2017-2019)
Figure Europe Synthetic Cannabinoids by Countries (2017-2019)
Figure Europe Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2019)
Figure Germany Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Germany Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Synthetic Cannabinoids Growth Rate (2017-2019)
Figure France Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Synthetic Cannabinoids Growth Rate (2017-2019)
Figure UK Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Russia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Italy Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Rest of Europe Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Asia-Pacific Synthetic Cannabinoids Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Synthetic Cannabinoids by Countries (2017-2019)
Figure Asia-Pacific Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2019)
Figure China Synthetic Cannabinoids Growth Rate (2017-2019)
Figure China Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Japan Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Korea Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Synthetic Cannabinoids Growth Rate (2017-2019)
Figure India Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Southeast Asia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Synthetic Cannabinoids Growth Rate (2017-2019)
Figure South America Synthetic Cannabinoids Revenue and Growth Rate (2017-2019)
Figure South America Synthetic Cannabinoids by Countries (2017-2019)
Figure South America Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Brazil Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Argentina Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Columbia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Rest of South America Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Middle East and Africa Synthetic Cannabinoids Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Synthetic Cannabinoids by Countries (2017-2019)
Figure Middle East and Africa Synthetic Cannabinoids Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Saudi Arabia Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Synthetic Cannabinoids Growth Rate (2017-2019)
Figure United Arab Emirates Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Egypt Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Nigeria Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Synthetic Cannabinoids Growth Rate (2017-2019)
Figure South Africa Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Turkey Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Synthetic Cannabinoids Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2017-2019)
Table Noramco Synthetic Cannabinoids Financial Overview
Table Lygos (Librede) Synthetic Cannabinoids Financial Overview
Table CV Sciences Synthetic Cannabinoids Financial Overview
Table Hyasynth Biologicals Synthetic Cannabinoids Financial Overview
Table Renew Biopharma Synthetic Cannabinoids Financial Overview
Table Insys Therapeutics Synthetic Cannabinoids Financial Overview
Table CannBioRx Life Sciences Synthetic Cannabinoids Financial Overview
Table Ginkgo Bioworks Synthetic Cannabinoids Financial Overview
Figure Global Synthetic Cannabinoids Revenue (Millions USD) and Growth Rate (2019-2027)
Table Synthetic Cannabinoids Market Forecast by Regions (2019-2027)
Figure North America Synthetic Cannabinoids Market Forecast (2019-2027)
Figure United States Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Canada Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Mexico Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Europe Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Germany Synthetic Cannabinoids Market Forecast (2019-2027)
Figure France Synthetic Cannabinoids Market Forecast (2019-2027)
Figure UK Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Russia Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Italy Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Rest of Europe Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Asia-Pacific Synthetic Cannabinoids Market Forecast (2019-2027)
Figure China Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Japan Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Korea Synthetic Cannabinoids Market Forecast (2019-2027)
Figure India Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Southeast Asia Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Synthetic Cannabinoids Market Forecast (2019-2027)
Figure South America Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Brazil Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Argentina Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Columbia Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Rest of South America Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Middle East and Africa Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Saudi Arabia Synthetic Cannabinoids Market Forecast (2019-2027)
Figure United Arab Emirates Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Egypt Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Nigeria Synthetic Cannabinoids Market Forecast (2019-2027)
Figure South Africa Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Turkey Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Synthetic Cannabinoids Market Forecast (2019-2027)
Figure Global Synthetic Cannabinoids Forecast by Type (2019-2027)
Figure Global Synthetic Cannabinoids Market Share Forecast by Type (2019-2027)
Figure Global Synthetic Cannabinoids Forecast by Type (2019-2027)
Figure Global Synthetic Cannabinoids Forecast by Applications (2019-2027)
Figure Global Synthetic Cannabinoids Market Share Forecast by Applications (2019-2027)
Figure Global Synthetic Cannabinoids Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|